← Back to Clinical Trials
Recruiting NCT07252713

NCT07252713 Complex Rehabilitation Technology Enabled Physical Activity for Children With Motor Delays Via Telehealth in Natural Environments

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07252713
Status Recruiting
Phase
Sponsor Ohio State University
Condition Cerebral Palsy (CP)
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2026-02-19
Primary Completion 2026-10

Eligibility & Interventions

Sex All sexes
Min Age 1 Year
Max Age 6 Years
Study Type INTERVENTIONAL
Interventions
Stander Use

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2026-02-19 with a primary completion date of 2026-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The primary goal of CP-MOVES is to evaluate 1) the preliminary efficacy of a telehealth-delivered, parent coaching intervention in the use of adaptive standers, on physical activity, sleep, and endurance in young children with severe motor delays and 2) on physical activity, sedentary time, resting heart rate, and perceived stress in parents. The main questions the study aims to answer include: 1. Do measures of physiological fitness and sleep in children with severe motor delays (i.e., unable to stand without support) change after a therapist-directed, parent-delivered intervention using telehealth and adaptive standers? 2. Do parents report any changes in their child's endurance, participation, or quality of life OR parent stress following intervention? Children ages 1-6 years old with severe motor delay and one parent will: 1. Complete three 30 minute sessions of standing in an adapted stander per week for 8 weeks. One session per week will be completed with a physical therapist, delivered through telehealth and two sessions per week will be completed as a home program with the parent and child (no therapist or telehealth). 2. Wear activity tracker sensors on the wrist(s) and waist for one-week before and after treatment. 3. Complete questionnaires about the child's endurance, participation, and quality of life and the parent's stress, before and after treatment. 4. Complete an assessment of postural control before and after treatment. 5. Complete an post-treatment interview

Eligibility Criteria

Inclusion Criteria: * Child age 1-6 years with CP or other severe motor delay (GMFCS IV-V); * Unable to stand without external support; * Parent willing and able to participate; * Internet access for telehealth; * Live within 50 miles of lab or willing to travel to OSU for pre and post testing and stander provision * One parent is fluent in English. Exclusion Criteria: * Inability to participate in telehealth * Parent/caregiver unable to participate

Frequently Asked Questions

Who can join the NCT07252713 clinical trial?

This trial is open to participants of all sexes, aged 1 Year or older, up to 6 Years, studying Cerebral Palsy (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07252713 currently recruiting?

Yes, NCT07252713 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ohio State University to inquire about joining.

Where is the NCT07252713 trial being conducted?

This trial is being conducted at Columbus, United States.

Who is sponsoring the NCT07252713 clinical trial?

NCT07252713 is sponsored by Ohio State University. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology